Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369–79. https://doi.org/10.1056/NEJMra1600266.
Article CAS PubMed Google Scholar
Ristig M, Drechsler H, Powderly WG. Hepatic steatosis and HIV infection. AIDS Patient Care STDS. 2005;19(6):356–65. https://doi.org/10.1089/apc.2005.19.356.
Aepfelbacher JA, Balmaceda J, Purdy J, et al. Increased prevalence of hepatic steatosis in young adults with lifelong HIV. J Infect Dis. 2019;220(2):266–9. https://doi.org/10.1093/infdis/jiz096.
Article PubMed PubMed Central Google Scholar
Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014;384(9939):241–8. https://doi.org/10.1016/S0140-6736(14)60604-8.
Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32(3):492–7. https://doi.org/10.1086/318501.
Article CAS PubMed Google Scholar
Gardner AR, Ma Y, Bacchetti P, et al. Longitudinal assessment of the enhanced liver fibrosis score in the era of contemporary HIV and hepatitis C virus treatment. J Infect Dis. 2022:jiac315. https://doi.org/10.1093/infdis/jiac315.
Price JC, Ma Y, Kuniholm MH, et al. Human immunodeficiency virus is associated with elevated FibroScan-Aspartate Aminotransferase (FAST) score. Clin Infect Dis. 2022;75(12):2119–27. https://doi.org/10.1093/cid/ciac337.
Maurice J, Manousou P. Non-alcoholic fatty liver disease. Clin Med (Lond). 2018;18(3):245–50. https://doi.org/10.7861/clinmedicine.18-3-245.
Kardashian A, Peters MG, Tien PC, Price JC. The pathogenesis of liver disease in people living with human immunodeficiency virus: the emerging role of the microbiome. Clin Liver Dis (Hoboken). 2020;15(1):46–51. https://doi.org/10.1002/cld.880.
Dillon SM, Frank DN, Wilson CC. The gut microbiome and HIV-1 pathogenesis: a two-way street. AIDS. 2016;30(18):2737–51. https://doi.org/10.1097/QAD.0000000000001289.
Article CAS PubMed Google Scholar
Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med. 2018;50(8):1–9. https://doi.org/10.1038/s12276-018-0126-x.
Article CAS PubMed Google Scholar
Blaschitz C, Raffatellu M. Th17 cytokines and the gut mucosal barrier. J Clin Immunol. 2010;30(2):196–203. https://doi.org/10.1007/s10875-010-9368-7.
Article CAS PubMed PubMed Central Google Scholar
Hunt PW, Sinclair E, Rodriguez B, et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J Infect Dis. 2014;210(8):1228–38. https://doi.org/10.1093/infdis/jiu238.
Article CAS PubMed PubMed Central Google Scholar
Schuetz A, Deleage C, Sereti I, et al. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLOS Pathogens. 2014;10(12):e1004543. https://doi.org/10.1371/journal.ppat.1004543.
Article CAS PubMed PubMed Central Google Scholar
Serrano-Villar S, Sainz T, Lee SA, et al. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 2014;10(5):e1004078. https://doi.org/10.1371/journal.ppat.1004078.
Article CAS PubMed PubMed Central Google Scholar
Burgener A, McGowan I, Klatt NR. HIV and mucosal barrier interactions: consequences for transmission and pathogenesis. Curr Opin Immunol. 2015;36:22–30. https://doi.org/10.1016/j.coi.2015.06.004.
Article CAS PubMed Google Scholar
Raffatellu M, Santos RL, Verhoeven DE, et al. Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med. 2008;14(4):421–8. https://doi.org/10.1038/nm1743.
Article CAS PubMed PubMed Central Google Scholar
Kumar P, Monin L, Castillo P, et al. Intestinal interleukin-17 receptor signaling mediates reciprocal control of the gut microbiota and autoimmune inflammation. Immunity. 2016;44(3):659–71. https://doi.org/10.1016/j.immuni.2016.02.007.
Article CAS PubMed PubMed Central Google Scholar
Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 2010;6(8):e1001052. https://doi.org/10.1371/journal.ppat.1001052.
Article CAS PubMed PubMed Central Google Scholar
Estes JD, Wietgrefe S, Schacker T, et al. Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection. J Infect Dis. 2007;195(4):551–61. https://doi.org/10.1086/510852.
Article CAS PubMed Google Scholar
Somsouk M, Estes JD, Deleage C, et al. Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS. 2015;29(1):43–51. https://doi.org/10.1097/QAD.0000000000000511.
Article CAS PubMed Google Scholar
Chitre AS, Kattah MG, Rosli YY, et al. A20 upregulation during treated HIV disease is associated with intestinal epithelial cell recovery and function. PLoS Pathog. 2018;14(3):e1006806. https://doi.org/10.1371/journal.ppat.1006806.
Article CAS PubMed PubMed Central Google Scholar
Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365–71. https://doi.org/10.1038/nm1511.
Article CAS PubMed Google Scholar
Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203(6):780–90. https://doi.org/10.1093/infdis/jiq118.
Article CAS PubMed PubMed Central Google Scholar
Vujkovic-Cvijin I, Dunham RM, Iwai S, et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med. 2013;5(193):193ra91. https://doi.org/10.1126/scitranslmed.3006438.
Article CAS PubMed PubMed Central Google Scholar
Lozupone CA, Li M, Campbell TB, et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe. 2013;14(3):329–39. https://doi.org/10.1016/j.chom.2013.08.006.
Article CAS PubMed Google Scholar
Nganou-Makamdop K, Talla A, Sharma AA, et al. Translocated microbiome composition determines immunological outcome in treated HIV infection. Cell. 2021;184(15):3899-3914.e16. https://doi.org/10.1016/j.cell.2021.05.023.
Article CAS PubMed PubMed Central Google Scholar
Bhat M, Arendt BM, Bhat V, Renner EL, Humar A, Allard JP. Implication of the intestinal microbiome in complications of cirrhosis. World J Hepatol. 2016;8(27):1128–36. https://doi.org/10.4254/wjh.v8.i27.1128.
Article PubMed PubMed Central Google Scholar
Tripathi A, Debelius J, Brenner DA, et al. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15(7):397–411. https://doi.org/10.1038/s41575-018-0011-z.
Article CAS PubMed PubMed Central Google Scholar
Hyun J, McMahon RS, Lang AL, et al. HIV and HCV augments inflammatory responses through increased TREM-1 expression and signaling in Kupffer and Myeloid cells. PLoS Pathog. 2019;15(7):e1007883. https://doi.org/10.1371/journal.ppat.1007883.
Article CAS PubMed PubMed Central Google Scholar
Le Roy T, Llopis M, Lepage P, et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut. 2013;62(12):1787–94. https://doi.org/10.1136/gutjnl-2012-303816.
Article CAS PubMed Google Scholar
Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4):913-916.e7. https://doi.org/10.1053/j.gastro.2012.06.031.
Article CAS PubMed Google Scholar
Boursier J, Mueller O, Barret M, et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 2016;63(3):764–75. https://doi.org/10.1002/hep.28356.
Article CAS PubMed Google Scholar
Csak T, Velayudham A, Hritz I, et al. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol. 2011;300(3):G433-441. https://doi.org/10.1152/ajpgi.00163.2009.
Article CAS PubMed PubMed Central Google Scholar
Fianchi F, Liguori A, Gasbarrini A, Grieco A, Miele L. Nonalcoholic fatty liver disease (NAFLD) as model of gut–liver axis interaction: from pathophysiology to potential target of treatment for personalized therapy. Int J Mol Sci. 2021;22(12):6485. https://doi.org/10.3390/ijms22126485.
留言 (0)